Search

everythinglearnresearchcommunity

for

Search:↓

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Combining stem cell media with laser or microneedling can effectively regrow hair in alopecia areata.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

The treatment is a safe and effective option for hair regrowth in patchy alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with autism are more likely to develop alopecia areata than those without autism.

Alopecia areata is more common in women, often appears as patchy hair loss, and is usually treated with steroid injections and minoxidil.

Low serum ferritin levels are linked to more severe and longer-lasting alopecia areata in children.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

More lesions mean more severe alopecia areata.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Alopecia areata is more common in males, often appears as patchy hair loss, and is strongly linked to anemia.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.